Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS

Clinical trial NCT05153525 · UNKNOWN

Trial details

NCT number: NCT05153525
Sponsor: Tanta University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Start date: 2022-01-06
Primary completion: 2022-07-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.